The implanting clinician attempted to revise the proximal end of the stimulator and also removed a granuloma that was near the area where the stimulator fractured.In the midst of this operation the receiver came out of the stimulator, indicating to the implanting clinician that the stimulators had fractured and migrated, causing loss of therapy.On (b)(6) 2020, the patient had a revision in which both stimulators were removed and two new stimulators were implanted.The revision was completed without complication and the patient has reported receiving therapy.On (b)(6) 2020, the cr stated that the implanting clinician believes that the stimulator fracture resulting in migration is due to a granuloma forming around the stimulator and causing tension.The patient was reported to be doing well and no further issues were noted.Through a review of sterilization and packaging records for the respective product lots, stimwave has confirmed that the product was delivered sterile, no trend of infection is evident for lot #'s swo190414 and swo190424, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.Sterility of the stimwave device did not contribute to granuloma formation.The root cause of this complaint is due to a granuloma forming around the stimulators, causing them to fracture and migrate leading to a loss of therapy.
|